Curis Inc.

(CRIS)

By |

Profile

Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its products include CUDC-907, phosphatidylinositol-3-kinase and small molecule inhibitor of histone deacetylase.

Contact Information

Website: www.curis.com
Main Phone: +1 617 503-6500
Address: 4 Maguire Road
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NSD
Employees: 44
NAICS: Biological Produ
$ 2.94 ($ 0.12) (-3.92%)
Last Price 2.94 Change $ -0.12 Change % -3.92 Tick N/A
Bid 2.12 Bid Size 20,000.00 Ask N/A Ask Size 0.00
Open 3.02 High 3.02 Low 2.84 Prev Close 3.06
Last Trade Volume 584,178 52 Wk Hi 3.72 52 Wk Low 1.25
Market Cap 413.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 140,549,019.00 EPS (TTM) -0.48 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 25
Number of Buys 2 13
Number of Sells 2 12
Net Activity 0 12900
Last 10 Buys Shares
Ali Fattaey 1,000
Ali Fattaey 1,000
Kenneth J. Pienta 1,000
Kenneth J. Pienta 1,000
James R. Mcnab 1,000
Daniel R. Passeri 1,000
Kenneth I. Kaitin 1,000
Marc Rubin 1,000
Last 10 Sell Shares
Martyn D. Greenacre 1,000
Martyn D. Greenacre 1,000
Kenneth I. Kaitin 1,000
Kenneth I. Kaitin 1,000
Daniel R. Passeri 1,000
Daniel R. Passeri 1,000
Daniel R. Passeri 1,000
Daniel R. Passeri 1,000
Daniel R. Passeri 1,000
Daniel R. Passeri 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 5.33 5.33 5.33 5.33
Standard Deviation 2.08 2.08 2.08 2.08
Date of Most Recent Estimate 08/05/16 08/05/16 05/09/16 08/05/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1